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1. Introduction 
Various studies have shown that specific proteins 
of target cells bind added steroids: oestrogens [ 1,2] 
testosterone [3,4] and progesterone [5,7] . These 
proteins have been isolated from the cytosol of cell 
homogenates. When the active steroid has bound to 
the cytosol receptor protein, the complex migrates 
into the nucleus, as initially shown by Jensen [2] 
and Gorski [l] where it encounters another acceptor 
the nature of which is still unknown but may be a 
protein or DNA itself [7] . A similar succession of 
events appears to be involved in the mechanism of 
action of aldosterone at peripheral receptor sites. The 
studies of Edelman [g] and Swaneck [9, lo] led to 
the isolation of proteins obtained from the nuclear 
and cytoplasmic fractions of the rat kidney that bind 
tritiated aldosterone in vivo and these proteins have 
also been found in homogenates of other tissues of 
the rat. 
Alberti [ 1 l] extracted protein-bound aldosterone 
from nuclei of the mucosal cells of the toad bladder 
by sonication. Rousseau [12] showed, both in vivo 
and in vitro, that there were two classes of renal 
cytosol receptors for aldosterone. The type I receptors 
have a high affinity for aldosterone while type 2 
receptors have a high affinity for glucocorticoids. 
The present study shows that tritiated aldosterone 
binds to proteins of the cytosol when incubated with 
rat-kidney slices. The binding of tritiated aldosterone 
to soluble proteins of the nucleus and to the 
chromatin has also been observed; this binding is 
reduced in the presence of active steroids and not in 
the presence of inactive steroids. 
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2. Experimental 
2.1. Material and methods 
Male albino rats of the Wistar strain, 1 OO- 150 g 
in weight, were adrenalectomised 3-4 days prior 
to the experiments. They were fed ad libitum and 
given 0.9% NaCl (w/v) to drink. [ 1 ,2-3 H] aldosterone 
(44-50 Ci/mmol) was obtained from New England 
Nuclear. Unlabeled aldosterone, deoxycorticosterone, 
9arfluorocortisol were obtained from Ciba-Geigy 
(Basle) and spironolactone from Searle (Chicago). 
Centrifugation was carried out in a Martin Christ 
refrigerated centrifuge. All radioactive samples were 
counted for 10 mm at 0°C in a liquid scintillation 
spectrometer (Packard Company) with 38-45% 
efficiency. The proteins were determined by the 
method of Lowry [14] , using bovine serum albumin 
as a standard. 
2.2. Incubations 
The rats were killed by decapitation and the 
kidneys were removed, decapsulated, and cut into 
fine slices of 275 pm thickness. The slices from two 
kidneys were collected, placed into flasks con- 
taining 4 ml of a Krebs-bicarbonate buffer solution 
with glucose (1 g/l) TrasylolR (200 U/EKI) and 
undiluted [l ,2-3H]aldosterone (5.2 nM). During all 
these manipulations the flasks were kept in an ice 
bath. The flasks were then placed in a shaking 
incubator (Braun) for 1 hr at 24°C in an atmosphere 
of 95% oxygen, 5% CO*. 
2.3. Isolation of the nuclear pellet 
At the end of the incubation period the medium 
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was aspirated and the kidney slices were rinsed with 
iced incubation buffer and homogenised with 6 vol 
of 2.2 M sucrose, 3 mM in MgCls using a Potter- 
Elvehjem Teflon homogeniser. This procedure and 
other subsequent steps were carried out at 4’C. The 
homogenate was filtered through 4 layers of gauze; 
the filtrate was brought to a volume of 10 ml with 
the same sucrose MgCI, solution and then centrifu- 
ged at 100 000 g for 30 min. The floats and super- 
natants were discarded and the nuclear pellets were 
gently resuspensed in 10 ml of sucrose and recentri- 
fuged at 100 000 g for 30 min. 
2.4. Preparation of the soluble nuclear proteins 
From the washed nuclei, albumin and globulins 
were extracted by the addition of 0.15 M NaCl, 
pH 8, followed by centrifugation for 10 min at 
19 000 g, the operation being repeated twice. The 
supernatant contained the soluble nuclear proteins. 
2.5. Preparation of the chromatin 
Chromatin was subsequently extracted from the 
pellet free of soluble proteins, either with distilled 
water or in 2 M NaCl [13]. The pellet was manually 
homogenised by hand with a Potter-Elvehjem 
homogeniser and centrifuged at 10 000 g for 30 mm. 
The supernatant contains the chromatin or the 
desoxyribonucleoproteins. The extraction was 
repeated until the extract was no longer viscous. 
2.6. Preparation of the cytosol 
After incubation as described above, the kidney 
slices were homogenised in 6 vol of 0.25 M sucrose, 
3 mM in MgCla . The homogenates were centrifuged 
at 130 000 g for 60 min and the supernatant con- 
stituted the cytosol fraction. 
2.7. Separation of free and bound aldosterone 
One-ml aliquots of cytosol, nuclear fraction and 
chromatin were passed through a 20 X 1 cm column 
of Sephadex G-50 (fine mesh, particle size : 20-80 
pm). Protein-bound aldosterone was recovered in 
the excluded volume of the column. The aldosterone- 
protein complex was also precipitated from the 
supernatant fractions by addition of an equal volume 
of saturated (NH&Sod. 
The 50%~saturation (NH&S04 solutions were 
incubated for 30 min at 4’C and then centrifuged 
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at 20 000 g for 15 min, re-suspended in a freshly 
prepared solution of glycerol (200 g/l) (pH approx. 
7.4) containing 0.02 M ammonium bicarbonate and 
assayed for radioactivity and proteins as described. 
3. Results and discussion 
3.1. Binding of aldosterone to nuclear and cytosolic 
proteins 
The specific activity of the nucleoprotein- 
aldosterone complex was 130 + 12 fmol/mg protein 
(mean + standard deviation). That of the protein- 
aldosterone complex in the cytosol was 13 + 2.5 fmol/ 
mg protein; n = 12. 
3.2. Chromatography on Sephadex 
In the nuclear fraction, after separation of the 
bound form from the free aldosterone on Sephadex 
G-50, the bound material was divided into two 
portions and rechromatographed on columns of 
Sephadex G-100 or G-200 respectively. 
In the first case the bound hormone was totally 
excluded. In the second case, only 15% of the radio- 
activity was present in the excluded volume, indicating 
an association to a complex of a molecular weight 
exceeding 106. The fraction excluded is lower if the 
pH is less than 6 or at higher ionic strength. The 
Table 1 
Effect of various steroid hormones on the binding of 
[ 1 ,2-3H]aldosterone in the soluble nuclear proteins of 
rat kidneys 
Binding (%) 
Aldosterone 
Aldosterone + 17 p-oestradiol (180) 
Aldosterone 
Aldosterone + deoxycorticosterone (150) 
Aldosterone 
Aldosterone + 9wfluorocortisol(1:80) 
Aldosterone 
Aldosterone + spironolactone (1 :lO 000) 
100 
105 
100 
40 
100 
35 
100 
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The results are expressed in % of the values obtained in the 
presence of [1,2-3H]aldosterone only. Dose ratios in paren- 
theses. 
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remaining radioactivity (85%), although originally 
bound, was eluted in a volume equal to that occupied 
by the free aldosterone in a separate control chromato- 
graphy, indicating that the bound aldosterone dis- 
sociates into protein and free aldosterone during the 
2 hr necessary for the elution. 
Neither dithiothreitol or dimethylsulfoxide at 
10% (w/v) concentration, nor TrasylolR (200 U/EKI) 
(a trypsin inhibitor) stabilised the complex. In con- 
trast, the use of higher concentrations of glycerol 
(200-250 g/l) increased the stability of the complex 
but this slowed down the elution considerably. 
3.3. Specificity of the binding to soluble nuclear 
proteins 
The kidney slices were incubated in the presence 
of 0.26 nmol [ 1 ,2-3 Hlaldosterone and of an excess 
of the following steroids (dose ratio in parentheses) :
deoxycorticosterone (1: 50), 9cw-fluorocortisol(l:80), 
17&oestradiol( 1:80) or spironolactone (1: 10 000). 
This resulted in reduced binding except with 
oestradiol (table 1). These results confirm those 
obtained in vivo by Swaneck [lo] . These experiments 
of Swaneck and ours indicate that there is a relation- 
ship between the capacity of the steroids to bind to 
these proteins and their characteristics either as 
mineralocorticoids or as competitive inhibitors of 
mineralocorticoids. 
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